- Q1 2024 MaxCyte Inc Earnings Call TranscriptMay 07, 2024$3.93 (+0.51%)Earnings
- Q4 2023 MaxCyte Inc Earnings Call TranscriptMar 12, 2024$3.98 (+0.25%)Earnings
- Q3 2023 MaxCyte Inc Earnings Call TranscriptNov 08, 2023$3.35 (-1.47%)Earnings
- Preliminary Q3 2023 MaxCyte Inc Earnings Call TranscriptOct 04, 2023$3.27 (+9.00%)Earnings
- Q2 2023 MaxCyte Inc Earnings Call TranscriptAug 09, 2023$4.36 (-2.68%)Earnings
- MaxCyte Inc at William Blair Growth Stock Conference TranscriptJun 08, 2023
- Q1 2023 MaxCyte Inc Earnings Call TranscriptMay 10, 2023$4.65 (-0.64%)Earnings
- Q4 2022 MaxCyte Inc Earnings Call TranscriptMar 15, 2023$4.2 (+2.69%)Earnings
- MaxCyte Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Q3 2022 MaxCyte Inc Earnings Call TranscriptNov 09, 2022$6.1 (-9.36%)Earnings
- MaxCyte Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 MaxCyte Inc Earnings Call TranscriptAug 10, 2022$5.68 (+3.65%)Earnings
- MaxCyte Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 MaxCyte Inc Earnings Call TranscriptMay 09, 2022$4.84 (-4.35%)Earnings
- Q4 2021 MaxCyte Inc Earnings Call TranscriptMar 22, 2022$6.9 (+3.45%)Earnings
- MaxCyte Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- MaxCyte Inc at ShareSoc Webinar TranscriptFeb 08, 2022
- MaxCyte Inc at Proactive ONE2ONE Virtual Forum TranscriptDec 02, 2021
- MaxCyte Inc at Stephens Investment Conference (Virtual) TranscriptNov 29, 2021
- Q3 2021 MaxCyte Inc Earnings Call TranscriptNov 10, 2021$10.7 (-7.68%)Earnings
- Q2 2021 MaxCyte Inc Earnings Call TranscriptSep 13, 2021Earnings
Preliminary Q3 2023 MaxCyte Inc Earnings Call Transcript
Good day, everyone, and welcome to the MaxCyte third-quarter 2023 preliminary financial results conference call. Today's call is being recorded, and I would now like to turn the call over to Madar mid-August, Head of Investor Relations. Please go ahead, sir.
Thank you, Lisa, and good afternoon, everyone. My name is Sean Menarguez. I'm the Head of Investor Relations at MaxCyte. Thank you all for participating in today's conference call.
On the call for MaxCyte, we have Doug Doerfler, President and Chief Executive Officer; and Douglas J. Swirsky, Chief Financial Officer. During the call, management will review the preliminary third-quarter 2023 revenue results and updated full-year 2023 revenue guidance that we released at the close of the market today. After our prepared remarks, we will take questions. We plan to report our full financial results for the third quarter on November 8.
Before we begin, I need to read the following statement. Statements, comments made during this call may be forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)